Genevention is a bioinformatics company that brings together long-standing experience in semantic integration of biomedical big data, cutting-edge deep data analyses and sharp visualizations for interactive data exploration. Our aim is to combine these technologies to allow biomedical researchers, pharmaceutical engineers and bioinformaticians to discover disease-specific biomarkers, reveal novel correlations in datasets across different experiment types and easily enrich experimental data with information from the literature and external databases. Our services include the custom-tailored development of semantic data integration systems, the provision of expert-curated biomarker knowledge bases based on high-throughput-omics data and the investigation of biomedical big data using artificial intelligence approaches.
Dr. Thomas Lingner
CEO
Thomas is a data scientist with a strong background in computational biology. His expertise covers data mining & machine learning, high-throughput sequence analysis and metagenomics.
Prof. Dr. Stefan Bonn
Co-founder / Advisory Board
Stefan is a biochemist and computational biologist with a strong background in deep learning and data analysis.
Dr. Herbert Stadler
Co-founder / Advisory Board
Herbert is a neuroscientist and successful biotech entrepreneur.
Publications
|
Title: Fear circuit–based neurobehavioral signatures mirror resilience to chronic social stress in mouse
|
|---|
|
Title: 99mTc-HDP Labeling—A Non-Destructive Method for Real-Time Surveillance of the Osteogenic Differentiation Potential of hMSC during Ongoing Cell Cultures
|
|
Title: Enabling technologies towards personalization of scaffolds for large bone defect regeneration
|
|
Title: Early life adversity targets the transcriptional signature of hippocampal NG2+ glia and affects voltage gated sodium (Na v) channels properties
|
|
Title: Interactive gene networks with KNIT
|
